Stay updated on Selinexor Maintenance in p53 Wild-Type Endometrial Carcinoma Clinical Trial

Sign up to get notified when there's something new on the Selinexor Maintenance in p53 Wild-Type Endometrial Carcinoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Selinexor Maintenance in p53 Wild-Type Endometrial Carcinoma Clinical Trial page

  1. Check
    4 days ago
    Change Detected
    Summary
    Revision: v3.6.3 was recorded in the page history, replacing v3.6.2. This is a minor version update and does not change the study details or user-visible content.
    Difference
    0.0%
    Check dated 2026-07-04T05:18:19.000Z thumbnail image
  2. Check
    11 days ago
    Change Detected
    Summary
    The revision history now displays v3.6.2 as the current page version, replacing the previous v3.6.0. This indicates the page content has been refreshed to a newer version.
    Difference
    0.0%
    Check dated 2026-06-27T03:10:38.000Z thumbnail image
  3. Check
    18 days ago
    No Change Detected
  4. Check
    25 days ago
    Change Detected
    Summary
    The study page now notes that recruitment is closed and no longer accepting participants.
    Difference
    0.2%
    Check dated 2026-06-12T16:31:19.000Z thumbnail image
  5. Check
    33 days ago
    Change Detected
    Summary
    The recruitment status was updated to Active, not recruiting; enrollment and site counts were revised (276 estimated to 257 actual; 217 locations to 204), and the page version was bumped to v3.5.5.
    Difference
    15%
    Check dated 2026-06-05T12:07:23.000Z thumbnail image
  6. Check
    54 days ago
    Change Detected
    Summary
    The study page was updated to Revision: v3.5.4, representing an internal update to the page's revision history. It does not modify any study details, endpoints, or inclusion criteria visible to users.
    Difference
    0.0%
    Check dated 2026-05-15T02:11:12.000Z thumbnail image
  7. Check
    61 days ago
    Change Detected
    Summary
    The Taiwan site listing was updated from 'Taoyuan, Taiwan, 333' to 'Taoyuan City, Taiwan, 333' to clarify the precise city designation. This clarifies the recruitment location for that site within the study's geographic footprint.
    Difference
    0.0%
    Check dated 2026-05-07T22:27:51.000Z thumbnail image

Stay in the know with updates to Selinexor Maintenance in p53 Wild-Type Endometrial Carcinoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Selinexor Maintenance in p53 Wild-Type Endometrial Carcinoma Clinical Trial page.